Related Experiment Video
Updated: Jul 20, 2026
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
[SQUID-biosusceptometry in iron overloaded patients with hematologic diseases]
P Nielsen1, U Kordes, R Fischer
1Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Hamburg-Eppendorf, Germany. nielsen@uke.uni-hamburg.de
Insights
Accurate monitoring of iron overload is vital for patient survival. SQUID-biosusceptometry offers reliable, non-invasive liver iron quantification, improving treatment adjustments for iron-chelating therapy.
Area of Science:
- Biomedical Engineering
- Medical Physics
- Hematology
Context:
- Iron overload, particularly post-transfusion siderosis, necessitates precise monitoring for effective treatment.
- Early and adjusted iron chelation therapy is critical for long-term survival, especially in pediatric patients.
- Accurate diagnostic parameters are essential for managing individual iron burden.
Purpose:
- To evaluate the efficacy of SQUID-biosusceptometry for non-invasive liver iron quantification in a large cohort of patients with secondary siderosis.
- To establish a new therapeutic index (DFO-index) for deferoxamine treatment that utilizes liver iron concentration for more accurate assessment of overdosing.
Summary:
- SQUID-biosusceptometry was used to quantify liver and spleen iron concentrations in 1112 patients with post-transfusion siderosis between 1989 and 2001.
- Whole-body iron stores were calculated based on these quantified iron concentrations.
- A retrospective analysis confirmed the benefit of SQUID-biosusceptometry for non-invasive liver iron measurement.
Impact:
- The study validates SQUID-biosusceptometry as a valuable tool for assessing iron burden in patients with secondary siderosis.
- The newly defined DFO-index provides a more reliable method for monitoring deferoxamine therapy, preventing overdosing and improving patient outcomes.
- This research contributes to optimizing the management of iron-loaded patients, enhancing long-term survival and quality of life.
Background:
For the long-term survival of iron-loaded patients, early and well adjusted treatment with iron chelators is of crucial importance, especially in children. Basis of the adequate treatment are appropriate diagnostic parameters which are capable to monitor the range of the individual iron burden.
Patients:
In the time period between 1989 and 2001, the status of iron loading was investigated in 1112 patients with post transfusion siderosis.
Methods:
The iron concentration in liver and spleen was quantified by SQUID-biosusceptometry. Using these values, the whole body iron stores were calculated.
Results And Discussion:
Based on a large number of patients with secondary siderosis, the benefit of SQUID-biosusceptometry for non-invasive liver iron quantification was evaluated retrospectively. In patients under treatment with deferoxamin, a new therapeutic DFO-index was defined which respects liver iron concentration instead of serum ferritin. This results in a more reliable information about DFO overdosing in a given patient.
More Related Videos
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry (CE-ICP-MS) for Quantification of Iron Redox Species (Fe(II), Fe(III))
Published on: May 4, 2020
05:08Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022